Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Bora Biologics today announced the successful completion of its first 2,000-liter engineering, scale up, and process confirmation run at its ...

The growing emphasis on CLD is evident in market projections. The global cell line development market is expected to expand ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to ...

Lotte Biologics Co., the biotech arm of Lotte Group, said Wednesday it has signed a contract with a U.S.-based oncology ...

The program leverages Just - Evotec Biologics' advanced biomanufacturing platform to deliver high-quality, scalable, ...

As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...

HCW Biologics Inc. and WY Biotech Co., Ltd. have finalized a licensing agreement for the development and commercialization of HCW11-006, a novel immunotherapy targeting age-related diseases and cancer ...

AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM for integrating the Leap-In transposase expression platform into its services. With this ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won "Biologics CDMO of the Year" (Large CDMOs) in ...

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ /6821.HK), recently announced that its Fengxian commercial ...